rLVS(delta) capB/Yp F1-V single vector platform vaccine expressing Yersinia pestis F1 and LcrV antigens provides complete protection against lethal respiratory challenge with virulent plague bacilli

By sjmartinez • May 27, 2025

Jia Q, Bowen RA, Masleša-Galić S, Horwitz MA. rLVS ΔcapB/Yp F1-V single vector platform vaccine expressing Yersinia pestis F1 and LcrV antigens provides complete protection against lethal respiratory challenge with virulent plague bacilli. Hum Vaccin Immunother. 2025 Dec;21(1):2507475. doi: 10.1080/21645515.2025.2507475. Epub 2025 May 26. PMID: 40417828.

Tags: bioterrorism, F1, Francisella tularensis, Infectious Diseases, LcrV, LVS ΔcapB, plague, Publications, single vector platform vaccine, Tier 1 select agent, vaccine, Yersinia pestis

The Effect of Low Dose Methotrexate on Arterial Inflammation in Persons Living with Human Immunodeficiency Virus. A double-blind randomized placebo-controlled pilot trial

Tawakol A, Ribaudo H, McKhann A, Bellinge JW, Zureigat H, Fayad ZA, Lederman MM, Grinspoon SK, Kuritzkes DR, Stein JH, Ridker PM, Currier JS, Hsue[...]

Associations Between Prior and Current Unhealthy Alcohol Use and Liver Morbidity Risk and Mortality Among Veterans With a History of Hepatitis C Who Have Achieved Sustained Virological Response

Feelemyer J, Ban FK, Braithwaite RS, Bhattacharya D, Caniglia EC, Justice AC, Lim JK, Re VL, Scheidell J, Rentsch CT, Khan M. Associations Between Prior[...]

Baseline ECG and Cardiovascular Outcomes in People With HIV: Insights From REPRIEVE

Awwad A, de Filippi C, Ribaudo H, Zanni MV, Fichtenbaum CJ, Malvestutto CD, Aberg JA, Diggs MR, Chu SM, Lu AB, Sponseller CA, Bagchi S,[...]